211 related articles for article (PubMed ID: 17475450)
1. In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria.
Gómez-Garcés JL; Alos JI; Tamayo J
Int J Antimicrob Agents; 2007 Jun; 29(6):688-92. PubMed ID: 17475450
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum.
Sánchez Hernández J; Mora Peris B; Yagüe Guirao G; Gutiérrez Zufiaurre N; Muñoz Bellido JL; Segovia Hernández M; García Rodríguez JA
Int J Antimicrob Agents; 2003 Nov; 22(5):492-6. PubMed ID: 14602367
[TBL] [Abstract][Full Text] [Related]
3. [Antibiotic sensitivity of Corynebacterium amycolatum].
Zalas P; Mikucka A; Gospodarek E
Med Dosw Mikrobiol; 2004; 56(4):327-34. PubMed ID: 15959988
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium.
Fernandez-Roblas R; Adames H; Martín-de-Hijas NZ; Almeida DG; Gadea I; Esteban J
Int J Antimicrob Agents; 2009 May; 33(5):453-5. PubMed ID: 19153032
[TBL] [Abstract][Full Text] [Related]
5. In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
Athamna A; Athamna M; Medlej B; Bast DJ; Rubinstein E
J Antimicrob Chemother; 2004 Apr; 53(4):609-15. PubMed ID: 14998982
[TBL] [Abstract][Full Text] [Related]
6. [Activity of new quinolones against clinical isolates of Corynebacterium species].
Yagüe Guirao G; Martínez-Toldos MC; Mora Peris B; López Domínguez R; Romero Otero M; Muñoz Bellido JL; Segovia Hernández M
Rev Esp Quimioter; 2000 Sep; 13(3):267-70. PubMed ID: 11086275
[TBL] [Abstract][Full Text] [Related]
7. Activities of gemifloxacin and five other antimicrobial agents against Listeria monocytogenes and coryneform bacteria isolated from clinical samples.
Martínez-Martínez L; Joyanes P; Suárez AI; Perea EJ
Antimicrob Agents Chemother; 2001 Aug; 45(8):2390-2. PubMed ID: 11451706
[TBL] [Abstract][Full Text] [Related]
8. High frequency of macrolide resistance mechanisms in clinical isolates of Corynebacterium species.
Ortiz-Pérez A; Martín-de-Hijas NZ; Esteban J; Fernández-Natal MI; García-Cía JI; Fernández-Roblas R
Microb Drug Resist; 2010 Dec; 16(4):273-7. PubMed ID: 20624090
[TBL] [Abstract][Full Text] [Related]
9. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
Huang YT; Liao CH; Teng LJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
[TBL] [Abstract][Full Text] [Related]
10. Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci.
Livermore DM; Mushtaq S; Warner M; Woodford N
J Antimicrob Chemother; 2009 Apr; 63(4):713-5. PubMed ID: 19164418
[TBL] [Abstract][Full Text] [Related]
11. Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.
Cabellos C; Garrigós C; Taberner F; Force E; Pachón-Ibañez ME
J Infect Chemother; 2014 Sep; 20(9):563-8. PubMed ID: 24973908
[TBL] [Abstract][Full Text] [Related]
12. Isolation of coryneform bacteria from blood cultures of patients at a University Hospital in Saudi Arabia.
Babay HA; Kambal AM
Saudi Med J; 2004 Aug; 25(8):1073-9. PubMed ID: 15322601
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
Antimicrob Agents Chemother; 2003 Jan; 47(1):337-41. PubMed ID: 12499210
[TBL] [Abstract][Full Text] [Related]
14. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
Domenech A; Ribes S; Cabellos C; Taberner F; Tubau F; Domínguez MA; Montero A; Liñares J; Ariza J; Gudiol F
J Antimicrob Chemother; 2005 Oct; 56(4):709-16. PubMed ID: 16120625
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of opportunistic species of the Corynebacterium and related coryneforms isolated from different clinical materials.
Chudnicka A; Kozioł-Montewka M
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):385-91. PubMed ID: 15315020
[TBL] [Abstract][Full Text] [Related]
16. In vitro antibacterial activities of a novel oxazolidinone, OCID0050.
Paul-Satyaseela M; Solanki SS; Sathishkumar D; Bharani T; Magesh V; Rajagopal S
J Antimicrob Chemother; 2009 Oct; 64(4):797-800. PubMed ID: 19689978
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
Erturan Z; Uzun M
Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
[TBL] [Abstract][Full Text] [Related]
18. [Implication of ermX genes in macrolide- and telithromycin-resistance in Corynebacterium jeikeium and Corynebacterium amycolatum].
Yagüe Guirao G; Mora Peris B; Martínez-Toldos MC; Rodríguez González T; Valero Guillén PL; Segovia Hernández M
Rev Esp Quimioter; 2005 Sep; 18(3):236-42. PubMed ID: 16369667
[TBL] [Abstract][Full Text] [Related]
19. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
Allen GP; Bierman BC
Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921
[TBL] [Abstract][Full Text] [Related]
20. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid.
Escribano I; Rodríguez JC; Llorca B; García-Pachon E; Ruiz M; Royo G
Chemotherapy; 2007; 53(6):397-401. PubMed ID: 17934259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
